Add-on grade-ranking scale for assessing thrombotic risk in patients with ischemic heart disease and percutaneous

Nadezhda V Storozhuk1, Aleksey B Panasenko2, Boris G Storozhuk1

  • 1National Pirogov Memorial Medical University, Vinnytsia, Ukraine.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 18, 2019
PubMed

Insights

This study developed a new risk scale to predict thrombotic complications in patients undergoing coronary angioplasty. The scale uses key hemostasis markers and patient history to accurately identify high-risk individuals.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biostatistics

Background:

  • Thrombotic complications are a significant risk following coronary angioplasty.
  • Accurate risk stratification is crucial for preventing adverse events in these patients.
  • Existing risk assessment tools may not fully capture the complexity of hemostatic changes.

Purpose of the Study:

  • To develop an informative grade-ranking scale for predicting thrombotic complications after coronary angioplasty.
  • To utilize principal component analysis to simplify complex hemostatic data.
  • To create a matrix for efficient patient classification based on thrombotic risk.

Main Methods:

  • Analysis of data from 70 patients with coronary heart disease undergoing percutaneous coronary angioplasty.
  • Measurement of soluble fibrin (rf), fibrinogen (fg), D-dimer (dd), and protein C (pc) levels.
  • Inclusion of diabetes mellitus and history of restenosis in the risk assessment model.

Main Results:

  • Principal component analysis identified two key matrices explaining 70% of data variance: (rf+dd) and (fg+pc).
  • These components formed the basis for an initial thrombotic risk indicator.
  • A second indicator, (rf/dd×100), incorporating diabetes and restenosis history, further refined risk assessment.

Conclusions:

  • The developed grade-ranking scale effectively predicts thrombotic complications in patients undergoing coronary angioplasty.
  • The scale offers a simplified yet informative approach to risk stratification.
  • This tool can aid clinicians in proactively managing patients at high risk of thrombotic events.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
353
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
186
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
200
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
683
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
211
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
210